home / stock / nvzmf / nvzmf short
Short Information | Novozymes A/S (OTCMKTS:NVZMF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,658 |
Total Actual Volume | 17,652 |
Short Trends | |
---|---|
Cover Days | 8 |
Short Days | 12 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 333 |
Average Short Percentage | 60.60% |
Is there a NVZMF Short Squeeze or Breakout about to happen?
See the NVZMF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-11-2024 | $63 | $61.1 | $63 | $61.1 | 140 | 48 | 34.29% |
07-10-2024 | $62.516 | $62 | $62.516 | $59.888 | 507 | 403 | 79.49% |
07-09-2024 | $62.605 | $62.625 | $62.625 | $62.605 | 324 | 324 | 100% |
07-08-2024 | $0 | $59.32 | $0 | $0 | 523 | 523 | 100% |
06-25-2024 | $60.68 | $62.01 | $62.01 | $60.68 | 480 | 250 | 52.08% |
06-21-2024 | $61.48 | $62.5 | $62.5 | $61 | 492 | 468 | 95.12% |
06-20-2024 | $64.71 | $65.4 | $65.4 | $63.02 | 2,886 | 41 | 1.42% |
06-14-2024 | $57.42 | $58.5958 | $58.5958 | $57.42 | 3,003 | 205 | 6.83% |
06-07-2024 | $61.35 | $61.35 | $61.35 | $61.35 | 81 | 81 | 100% |
06-06-2024 | $63.4 | $59.7 | $63.4 | $59.7 | 75 | 20 | 26.67% |
06-05-2024 | $61.32 | $61.62 | $61.62 | $59 | 1,274 | 24 | 1.88% |
05-22-2024 | $61.05 | $61.05 | $61.05 | $61.05 | 56 | 55 | 98.21% |
05-21-2024 | $60.6975 | $60.6975 | $60.6975 | $60.6975 | 960 | 185 | 19.27% |
05-17-2024 | $62.5 | $62.09 | $62.5 | $62.09 | 1,796 | 1,750 | 97.44% |
05-01-2024 | $53.5 | $57.15 | $57.15 | $53.5 | 1,136 | 220 | 19.37% |
04-30-2024 | $57.25 | $55.81 | $57.25 | $54.53 | 1,140 | 1,015 | 89.04% |
04-26-2024 | $55.76 | $53.32 | $55.7808 | $53.32 | 230 | 155 | 67.39% |
04-19-2024 | $55.7 | $54.45 | $56.45 | $54.45 | 2,169 | 511 | 23.56% |
04-17-2024 | $54.5 | $54.5 | $54.5 | $54.5 | 180 | 180 | 100% |
04-16-2024 | $55.79 | $55.79 | $55.79 | $55.79 | 200 | 200 | 100% |
News, Short Squeeze, Breakout and More Instantly...
After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth. The company confirms the 2023 outlook of 4-7% which is expected to be driven by pricing and volume growth. COPENHAGEN, Denmark – April 26, 2023. In the first three mon...
Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more than a decade, and Novozymes is confident about the 2023 outlook of 4-7%. COPENHAGEN, Denmark – January 26, ...
New York City, NY: May 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Enzyme Market in Global Industry: 2020 Research and New Innovations in Oil and Gas Sector. The prime objective of the report is to offer updates and information relate...